Invivo Theraptc Cm (NVIV) 5.47 $NVIV InVivo Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Invivo Theraptc Cm (NVIV) 5.47 $NVIV

InVivo Therapeutics to Present at 34th Annual Symposium of the National Neurotrauma Society
BusinessWire - Thu Jun 23, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that Richard Layer, Ph.D., InVivo's Senior Director of Research, will be giving a poster presentation at the National Neurotrauma Society (NNS) 2016 Symposium to be held June 26-29 in Lexington, KY. The abstract, titled "Biodegradable Neuro-Spinal Scaffold Promotes Neuropermissive Tissue Remodeling Following Spinal Contusion Injury in Rats" will be published electronically in the Journal of Neurotrauma immediately prior to the conference.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces Appointment of Christina Morrison to its Board of Directors
BusinessWire - Wed Jun 08, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Christina Morrison to its Board of Directors effective immediately. Most recently, Ms. Morrison served as the Senior Vice President of Finance for Aramark, where she was responsible for treasury, including oversight of over $5 billion of debt, global shared services, which processes certain accounting functions as well as certain human resource functions for over 120,000 employees, and mergers & acquisitions. She joined Aramark in June 2013 as Senior Vice President of Finance.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Featured on CBS Radio Affiliate
BusinessWire - Thu May 26, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company was featured in a WBZ NewsRadio 1030 (CBS - Boston) interview with New England Business reporter Jeff Brown. Mr. Brown has been with WBZ NewsRadio since 2012 and is a 30-year veteran of the broadcast industry. The interview aired a number of times on May 23 and May 24 with a total audience reach of nearly a half million listeners.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces Notice of Allowance for Patent Covering Methods of Treating Spinal Cord Injuries Using a Broad Array of Polymeric Implants, Including the Neuro-Spinal Scaffold(TM)
BusinessWire - Wed May 18, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/694,466, titled "Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries". The application covers methods of treatment of compression or contusion spinal cord injuries with a broad array of biodegradable and/or bioabsorbable polymeric implants that includes InVivo's Neuro-Spinal Scaffold(TM), which is currently being studied in the pivotal INSPIRE study. Of note, the allowed claims cover methods of use for a broader spectrum of polymeric compositions than claims in previously granted U.S. Patent No. 9,101,695 issued on August 11, 2015 and U.S. Patent No. 8,858,966 issued on October 14, 2014. InVivo is the exclusive licensee of this intellectual property for spinal cord injury and other indications through a license with Boston Children's Hospital and the Massachusetts Institute of Technology (MIT). A notice of allowance from the USPTO is a written notification that a patent application has cleared internal review and is pending issuance.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces Hospital of the University of Pennsylvania as New Site for INSPIRE Study
BusinessWire - Wed May 11, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Hospital of the University of Pennsylvania (HUP), a part of the University of Pennsylvania Health System in Philadelphia, PA, has been added as a clinical site for The INSPIRE Study.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Reports 2016 First Quarter Financial Results and Business Update
BusinessWire - Fri May 06, 3:30PM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended March 31, 2016.
NVIV: 5.47 (-0.16)

These 4 Small Cap Stocks Are Having Big Volume Days Today
ACCESSWIRE - Tue Apr 26, 9:38AM CDT
NEW YORK, NY / ACCESSWIRE / April 26, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Tuesday. SEED, OGXI, NVIV and TCS are on high volume alert. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
NVIV: 5.47 (-0.16), OGXI: 1.03 (+0.02), SEED: 1.83 (unch), TCS: 5.20 (-0.09)

InVivo Therapeutics Reports Conversion of a Fourth Patient Implanted with the Neuro-Spinal Scaffold(TM) in the INSPIRE Study
BusinessWire - Tue Apr 26, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the sixth-implanted patient in the INSPIRE study has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. This is the fourth out of the first six patients (67%) with at least two months of follow up data to have had an AIS grade improvement.
NVIV: 5.47 (-0.16)

InVivo Therapeutics to Present at Committee Roundtable on Biomedical Engineering Materials and Applications
BusinessWire - Wed Apr 20, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that Thomas Ulich, M.D., Chief Scientific Officer, is scheduled to present at the Committee Roundtable on Biomedical Engineering Materials and Applications (BEMA) to be held on Monday, April 25, 2016 in Washington, D.C. The topic of the session is "Neuro Devices and Neuro Regeneration".
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces John A. McCarthy, Jr. to Not Stand for Re-election
BusinessWire - Tue Apr 12, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that John A. McCarthy, Jr. has decided not to stand for re-election to the Board of Directors at the Company's 2016 Annual Meeting of the Stockholders. Mr. McCarthy is departing to devote more time to his role as Chief Executive Officer and a director of ZS Genetics, Inc. as well as his other business ventures. Mr. McCarthy will continue to serve as a director of the Company until the expiration of his term at the conclusion of the Company's 2016 Annual Meeting of Stockholders.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces University of Virginia Health System as New Site for INSPIRE Study
BusinessWire - Tue Apr 05, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the University of Virginia (UVA) Health System in Charlottesville, VA has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. The UVA Health System serves a large geographic area with a population base of approximately 800,000 in central Virginia and receives transfers from the rest of the state.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Featured in Life Science Leader
BusinessWire - Mon Apr 04, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company was featured in a Life Science Leader article titled "InVivo Therapeutics: Taking on Spinal Cord Injury" as part of The Enterprisers series.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces Enrollment of Seventh Patient into The INSPIRE Study
BusinessWire - Thu Mar 24, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that a seventh patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) at the Carolinas Medical Center in Charlotte, NC. Domagoj Coric, M.D., of Carolina Neurosurgery and Spine Associates, Chief of Neurosurgery at the Carolinas Medical Center and a member of the INSPIRE Study Steering Committee, performed the implantation approximately 21 hours after the injury occurred. He and Dr. William Bockenek, Chief Medical Officer at Carolinas Rehabilitation, are Co-Principal Investigators at this site.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Holdings Corp. Closes Exercise of Over-Allotment
BusinessWire - Wed Mar 23, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV), today announced the closing of the exercise of the over-allotment option granted to the underwriters in connection with its previously announced public offering. The underwriters purchased an additional 560,000 shares of InVivo's common stock, bringing the total proceeds of the offering to approximately $32.2 million, before deducting underwriting discounts and commissions and other estimated offering expenses, and excluding the exercise of any warrants. In connection with the initial closing of the offering on March 18, 2016, InVivo issued 3,733,333 units at a price of $7.50 per unit, each unit consisting of one share of common stock and .50 of a warrant to purchase a share of common stock at an exercise price of $10.00 per share. At the initial closing, the underwriters exercised their over-allotment option to purchase additional warrants to purchase an additional 280,000 shares of common stock. InVivo intends to use the net proceeds from this offering to fund ongoing clinical trials and for general corporate purposes.
NVIV: 5.47 (-0.16)

InVivo Therapeutics to Present at 2016 American Spinal Injury Association Annual Scientific Meeting
BusinessWire - Tue Mar 22, 7:00AM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that Lorianne Masuoka, M.D., Chief Medical Officer, is scheduled to present at the 2016 American Spinal Injury Association (ASIA) Annual Scientific Meeting to be held April 14-16, 2016 in Philadelphia, PA. Dr. Masuoka was invited to present along with several other leaders in the field of spinal cord injury clinical research on April 15th at 3:00 PM (EDT) during the symposium titled "Clinical Trials Update for 2016". The symposium, organized by the Spinal Cord Outcomes Partnership Endeavor (SCOPE), is intended to appeal to a wide audience of basic science researchers, clinical researchers, and spinal cord injury clinicians.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Holdings Corp. Announces Pricing of Public Offering of Common Stock and Warrants
BusinessWire - Tue Mar 15, 8:10AM CDT
InVivo Therapeutics Holdings Corp. (NVIV), today announced the pricing of an underwritten public offering of 3,733,333 units at a public offering price of $7.50 per unit. Each unit consists of one share of common stock and .50 of a warrant to purchase a share of common stock at an exercise price of $10.00 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the date of issuance. The shares of common stock and warrants are immediately separable and will be issued separately.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Holdings Corp. Announces Proposed Public Offering
BusinessWire - Mon Mar 14, 3:01PM CDT
InVivo Therapeutics Holdings Corp. (NVIV) today announced that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The shares of common stock and warrants to purchase shares of common stock are being offered as units. The shares of common stock and warrants will be immediately separable and will be issued separately. In connection with this offering, InVivo intends to grant the underwriters an option to purchase an additional 15% of the securities sold in the offering. All securities in the offering are being offered by InVivo. The offering is subject to market conditions and there can be no assurance as to whether the offering may be completed, or as to the actual size or terms of the offering. Raymond James & Associates, Inc. will act as the sole book-running manager in the offering.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Announces Thomas Jefferson University Hospital as New Site for INSPIRE Study
BusinessWire - Tue Mar 08, 7:00AM CST
InVivo Therapeutics Holdings Corp. (NVIV) today announced that Thomas Jefferson University Hospital has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. Thomas Jefferson University Hospital, in affiliation with the Magee Rehabilitation Hospital, is designated as one of the nation's 14 Spinal Cord Injury (SCI) Model Systems Centers by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). James Harrop, M.D., Professor of Neurological Surgery and Co-Director for Adult Reconstructive Spine, has been named Principal Investigator at the site.
NVIV: 5.47 (-0.16)

InVivo Therapeutics Reports Significant Improvement of Fifth Patient Implanted with the Neuro-Spinal Scaffold(TM) in INSPIRE Study
BusinessWire - Mon Mar 07, 7:00AM CST
InVivo Therapeutics Holdings Corp. (NVIV) today announced a six-month post-implant update for the fifth patient in The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury.
NVIV: 5.47 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 661

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 265

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 318

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 58

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 158

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Fundraising Initiative by Robin Hood for NYC

Updated Category News Views 459

Robin Hood Introduces a New Fundraising Venture In an exciting move that demonstrates their ongoing commitment to combating poverty, Robin Hood, New York's most extensive poverty-fighting organization, has launched a unique fundraising initiative titled 'The Robin Hood Pick-A-Ticker: A Fundraiser for Robin Hood (and your Favorite Charity!).' This initiative is made...

Continue Reading
Newell Brands Faces Analyst Downgrades After Earnings Release

Updated Category News Views 179

Newell Brands' Earnings Report: An Overview Newell Brands Inc. (NASDAQ: NWL) has recently reported its second-quarter earnings, revealing a mixed performance that has caught the attention of investors and analysts alike. Highlighting both earnings that met expectations and revenues that fell short, the company’s report has prompted analysts to adjust their projections...

Continue Reading
Smart Lock Market Projected Growth to US$ 16.47 Billion

Updated Category News Views 210

Smart Lock Market Value and Forecast The global smart lock market is experiencing significant growth, currently valued at approximately US$ 6.76 billion in 2024. Projections indicate that it will reach US$ 16.47 billion by 2033, showcasing a robust annual growth rate (CAGR) of 10.4% during this period. This growth can be attributed to a surge in consumer awareness...

Continue Reading
Analyzing UnitedHealth Group's Current Market Movement and Outlook

Updated Category News Views 191

Understanding the Options Activity of UnitedHealth Group In recent trading sessions, there has been notable bearish activity surrounding UnitedHealth Group (NYSE: UNH). High-profile investors seem to be indicating cautious sentiment toward this health insurance giant, which warrants the attention of retail traders. Insights from Recent Options Trading The trading data...

Continue Reading
Stan Bernard Steps Up as Zurich's New Head of Industry Practices

Updated Category News Views 261

Stan Bernard is Promoted to Lead Industry Practices at Zurich In an exciting development for Zurich North America, Stan Bernard has been appointed as the new Head of Industry Practices for the U.S. Middle Market. This significant promotion comes as Bernard takes over from Lynn Zeitler, who is retiring after an impressive 31-year career with the company. Bernard’s ascent...

Continue Reading